rs191830054

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_017721.5(CC2D1A):ā€‹c.1234A>Gā€‹(p.Ile412Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00277 in 1,603,876 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.0024 ( 0 hom., cov: 32)
Exomes š‘“: 0.0028 ( 5 hom. )

Consequence

CC2D1A
NM_017721.5 missense

Scores

5
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:4

Conservation

PhyloP100: 3.18
Variant links:
Genes affected
CC2D1A (HGNC:30237): (coiled-coil and C2 domain containing 1A) This gene encodes a transcriptional repressor that binds to a conserved 14-bp 5'-repressor element and regulates expression of the 5-hydroxytryptamine (serotonin) receptor 1A gene in neuronal cells. The DNA binding and transcriptional repressor activities of the protein are inhibited by calcium. A mutation in this gene results in a nonsyndromic form of cognitive disability (MRT3). [provided by RefSeq, Jul 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010265142).
BP6
Variant 19-13919829-A-G is Benign according to our data. Variant chr19-13919829-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 210590.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=3, Uncertain_significance=4}.
BS2
High Homozygotes in GnomAdExome4 at 5 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CC2D1ANM_017721.5 linkuse as main transcriptc.1234A>G p.Ile412Val missense_variant 12/29 ENST00000318003.11 NP_060191.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CC2D1AENST00000318003.11 linkuse as main transcriptc.1234A>G p.Ile412Val missense_variant 12/291 NM_017721.5 ENSP00000313601 P3Q6P1N0-1

Frequencies

GnomAD3 genomes
AF:
0.00242
AC:
368
AN:
152134
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00113
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00530
Gnomad ASJ
AF:
0.00634
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00113
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00298
Gnomad OTH
AF:
0.000956
GnomAD3 exomes
AF:
0.00238
AC:
590
AN:
248050
Hom.:
0
AF XY:
0.00237
AC XY:
319
AN XY:
134670
show subpopulations
Gnomad AFR exome
AF:
0.00110
Gnomad AMR exome
AF:
0.00405
Gnomad ASJ exome
AF:
0.00391
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000229
Gnomad FIN exome
AF:
0.00121
Gnomad NFE exome
AF:
0.00300
Gnomad OTH exome
AF:
0.00415
GnomAD4 exome
AF:
0.00281
AC:
4075
AN:
1451624
Hom.:
5
Cov.:
30
AF XY:
0.00275
AC XY:
1978
AN XY:
720566
show subpopulations
Gnomad4 AFR exome
AF:
0.000844
Gnomad4 AMR exome
AF:
0.00378
Gnomad4 ASJ exome
AF:
0.00412
Gnomad4 EAS exome
AF:
0.0000254
Gnomad4 SAS exome
AF:
0.000244
Gnomad4 FIN exome
AF:
0.000769
Gnomad4 NFE exome
AF:
0.00319
Gnomad4 OTH exome
AF:
0.00298
GnomAD4 genome
AF:
0.00242
AC:
368
AN:
152252
Hom.:
0
Cov.:
32
AF XY:
0.00232
AC XY:
173
AN XY:
74454
show subpopulations
Gnomad4 AFR
AF:
0.00113
Gnomad4 AMR
AF:
0.00530
Gnomad4 ASJ
AF:
0.00634
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00113
Gnomad4 NFE
AF:
0.00298
Gnomad4 OTH
AF:
0.000946
Alfa
AF:
0.00258
Hom.:
1
Bravo
AF:
0.00273
TwinsUK
AF:
0.00135
AC:
5
ALSPAC
AF:
0.00234
AC:
9
ESP6500AA
AF:
0.000803
AC:
3
ESP6500EA
AF:
0.00280
AC:
23
ExAC
AF:
0.00204
AC:
246
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00405
EpiControl
AF:
0.00451

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:3
Likely benign, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsSep 27, 2016- -
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenMar 01, 2024CC2D1A: BP4 -
Intellectual disability, autosomal recessive 3 Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingGenomic Research Center, Shahid Beheshti University of Medical SciencesMar 05, 2018- -
Uncertain significance, criteria provided, single submitterclinical testingBaylor GeneticsJan 07, 2019This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoAug 08, 2014- -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMay 27, 2020The p.I412V variant (also known as c.1234A>G), located in coding exon 12 of the CC2D1A gene, results from an A to G substitution at nucleotide position 1234. The isoleucine at codon 412 is replaced by valine, an amino acid with highly similar properties. This variant has co-occurred with variants in other intellectual disability (ID)-related genes in individuals from an ID cohort (Grozeva D et al. Hum. Mutat., 2015 Dec;36:1197-204). This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
CC2D1A-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesMar 18, 2022This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.21
BayesDel_addAF
Benign
-0.47
T
BayesDel_noAF
Benign
-0.44
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Benign
0.16
T;.
Eigen
Benign
-0.0039
Eigen_PC
Benign
0.11
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Uncertain
0.91
D;D
M_CAP
Benign
0.017
T
MetaRNN
Benign
0.010
T;T
MetaSVM
Benign
-0.94
T
MutationAssessor
Uncertain
2.6
M;M
MutationTaster
Benign
0.92
D;D
PrimateAI
Benign
0.46
T
PROVEAN
Benign
-0.82
N;.
REVEL
Benign
0.070
Sift
Uncertain
0.018
D;.
Sift4G
Benign
0.093
T;T
Polyphen
0.10
B;B
Vest4
0.15
MVP
0.34
MPC
0.31
ClinPred
0.031
T
GERP RS
4.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.098
gMVP
0.11

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.11
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs191830054; hg19: chr19-14030642; API